Published in Biochem Pharmacol on June 15, 1988
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. J Clin Oncol (2011) 1.60
Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest (1996) 1.49
Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment. Blood (2005) 0.93
Nucleoside salvage and resistance to antimetabolite anticancer agents. Br J Cancer (1991) 0.87
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity. Cancer Chemother Pharmacol (2014) 0.83
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol. BMC Cancer (2014) 0.80
Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism. Eur J Pharm Sci (2007) 0.76
Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin Cancer Res (2000) 1.91
Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child (1992) 1.86
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum (1998) 1.59
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet (1999) 1.48
Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr (1993) 1.47
Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol (2002) 1.42
Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem (1997) 1.24
Haemolytic-uraemic syndrome. Epidemiological and clinical study. Arch Dis Child (1974) 1.19
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis (1996) 1.16
Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem (1995) 1.15
Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol (2000) 1.12
Increased expression of heparanase in overt diabetic nephropathy. Kidney Int (2006) 1.11
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem Pharmacol (1993) 1.03
Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency. Clin Chim Acta (1984) 1.03
Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem (1998) 1.02
Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. Eur J Cancer (1997) 1.01
Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis (2002) 0.94
Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am J Hum Genet (1998) 0.94
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J Clin Invest (1995) 0.92
Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis. J Am Soc Nephrol (1999) 0.89
Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts. Biochem Pharmacol (1993) 0.89
Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Biochem Pharmacol (1986) 0.88
Argininosuccinic aciduria: clinical and biochemical findings in three children with the late onset form, with special emphasis on cerebrospinal fluid findings of amino acids and pyrimidines. Neuropediatrics (1993) 0.88
Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy. Diabetologia (1995) 0.88
Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts. Biochem J (1994) 0.87
Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine. Biochem Pharmacol (1995) 0.87
Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clin Chim Acta (1989) 0.86
Phytohaemagglutinin stimulation of peripheral lymphocytes in children with acute lymphoblastic leukaemia during remission. Scand J Haematol (1972) 0.86
2,8-Dihydroxyadenine stone formation in a renal transplant recipient due to adenine phosphoribosyltransferase deficiency. J Urol (1996) 0.86
Polyamines and DNA methylation in childhood leukaemia. Biochem Soc Trans (2007) 0.86
2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. Mol Genet Metab (2001) 0.85
Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia (1995) 0.85
Megaloblastic anaemia in the Lesch-Nyhan syndrome. Lancet (1968) 0.85
Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts. Biochem Pharmacol (1986) 0.84
Dihydropyrimidinase deficiency, a progressive neurological disorder? Neuropediatrics (1997) 0.84
Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis Rheum (1995) 0.83
Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem (2003) 0.83
5-nucleotidase and azathioprine-related bone-marrow toxicity. Lancet (1993) 0.83
Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells. Cancer Lett (1998) 0.83
Sideroblastic anaemia. A review of seven paediatric cases. Eur J Pediatr (1982) 0.83
Dihydropyrimidine dehydrogenase deficiency. Neurological aspects. J Neurol Sci (1987) 0.82
Pitfalls in the determination of mutant alleles of the thiopurine methyltransferase gene. Leukemia (2001) 0.82
The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts. Biochim Biophys Acta (1993) 0.82
Disturbances of cerebral purine and pyrimidine metabolism in young children with chronic renal failure. Nephron (1991) 0.81
Citrullinaemia with rapidly fatal neonatal course. Arch Dis Child (1971) 0.81
The influence of adenine on the clinical features and purine metabolism in the Lesch-Nyhan syndrome. Acta Paediatr Scand (1970) 0.81
Purine enzymes in rheumatoid arthritis: possible association with response to azathioprine. A pilot study. Ann Rheum Dis (1994) 0.81
Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats. Nephron (1997) 0.81
Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. Lab Invest (1991) 0.80
Increase of HLA-"DRw6" in patients with juvenile chronic arthritis. Tissue Antigens (1983) 0.80
Purine enzyme activities in peripheral blood mononuclear cells: comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure. J Chromatogr B Biomed Appl (1995) 0.79
Determination of extracellular and intracellular thiopurines and methylthiopurines by high-performance liquid chromatography. J Chromatogr B Biomed Appl (1995) 0.79
Increased availability of phosphoribosyl pyrophosphate as the basis for enhanced 6-mercaptopurine incorporation by methotrexate, in cultured human lymphoblasts. Adv Exp Med Biol (1986) 0.79
Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages. Biochem Pharmacol (1988) 0.79
Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats. Clin Exp Immunol (1996) 0.79
Identification of a four-base deletion (delTCAT296-299) in the dihydropyrimidine dehydrogenase gene with variable clinical expression. Hum Genet (1997) 0.79
Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem (1994) 0.79
Purine enzymes in rheumatoid arthritis. A clue to the prediction of the response to azathioprine? Review and hypothesis. Clin Exp Rheumatol (1995) 0.79
Biochemical evidence for synergistic combination treatment with methotrexate and 6-mercaptopurine in acute lymphoblastic leukemia. Haematol Blood Transfus (1990) 0.78
A patient with a deficiency of serum-carnosinase activity. Acta Paediatr Scand (1969) 0.78
Detection and identification of 6-methylmercapto-8-hydoxypurine, a major metabolite of 6-mercaptopurine, in plasma during intravenous administration. Clin Chem (1996) 0.78
Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation. J Inherit Metab Dis (1998) 0.78
DNA methylation patterns in the calcitonin gene region at first diagnosis and at relapse of acute lymphoblastic leukemia (ALL). Leukemia (1997) 0.78
A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line. Biochim Biophys Acta (1993) 0.78
Pyrimidine metabolism in erythrocytes of the newborn. Biol Neonate (1979) 0.78
Reduced purine 5'-nucleotidase activity in lymphocytes of patients with systemic lupus erythematosus: results of a pilot study. Ann Rheum Dis (1999) 0.78
Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. Am J Pathol (1995) 0.78
Inhibition of DNA methylation in malignant MOLT F4 lymphoblasts by 6-mercaptopurine. Clin Chem (1998) 0.78
Purine enzyme activities in recent onset rheumatoid arthritis: are there differences between patients and healthy controls? Ann Rheum Dis (1996) 0.78
Concentration of purine nucleotides in erythrocytes of patients with the Lesch-Nyhan syndrome before and during oral administration of adenine. Acta Paediatr Scand (1971) 0.78
High-performance liquid chromatographic assay for identification and quantitation of nucleotides in lymphocytes and malignant lymphoblasts. J Chromatogr (1982) 0.77
The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphate. Biochem Pharmacol (1995) 0.77
Concentration of nucleotides and deoxynucleotides in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes. Effects of adenosine and deoxyadenosine. Biochim Biophys Acta (1983) 0.77
The urinary excretion of orotic acid and orotidine, measured by an isotope dilution assay. Clin Chim Acta (1978) 0.77
High-performance liquid chromatographic determination of purine and pyrimidine bases, ribonucleosides, deoxyribonucleosides and cyclic ribonucleotides in biological fluids. J Chromatogr (1982) 0.76
Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts. Ann Clin Biochem (1994) 0.76
Mechanism of allopurinol-mediated inhibition and stabilization of human orotate phosphoribosyltransferase and orotidine phosphate decarboxylase. Biochem Pharmacol (1976) 0.76
Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat. Nephrol Dial Transplant (1997) 0.76
Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. Adv Exp Med Biol (1998) 0.76
Purine metabolism in childhood acute lymphoblastic leukemia: biochemical markers for diagnosis and chemotherapy. Leuk Res (1983) 0.76
Morphology and incidence of the "posttherapeutic lymphoid cell" in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol (1986) 0.76
A patient with nonketotic hyperglycinemia: biochemical findings and therapeutic approaches. Pediatr Res (1974) 0.75
Biphasic effect of adenosine on cell growth and cell cycle of human lymphoid cell lines. Adv Exp Med Biol (1986) 0.75
Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts. Klin Padiatr (1992) 0.75